Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Surgical Flaps | 3 | 2018 | 22 | 1.180 |
Why?
|
| Reconstructive Surgical Procedures | 2 | 2018 | 72 | 1.120 |
Why?
|
| Herniorrhaphy | 2 | 2022 | 17 | 0.700 |
Why?
|
| Skin Transplantation | 2 | 2022 | 14 | 0.660 |
Why?
|
| Abdominal Wall | 1 | 2019 | 9 | 0.660 |
Why?
|
| Surgical Mesh | 1 | 2019 | 14 | 0.660 |
Why?
|
| Tensile Strength | 1 | 2019 | 32 | 0.650 |
Why?
|
| Weight Loss | 2 | 2019 | 72 | 0.640 |
Why?
|
| Thigh | 1 | 2018 | 39 | 0.610 |
Why?
|
| Femoral Artery | 1 | 2018 | 58 | 0.600 |
Why?
|
| Myocutaneous Flap | 1 | 2017 | 3 | 0.590 |
Why?
|
| Neck | 1 | 2017 | 25 | 0.580 |
Why?
|
| Mammary Arteries | 1 | 2017 | 6 | 0.580 |
Why?
|
| Head | 1 | 2017 | 16 | 0.580 |
Why?
|
| Salvage Therapy | 1 | 2017 | 32 | 0.580 |
Why?
|
| Thoracic Arteries | 1 | 2014 | 1 | 0.470 |
Why?
|
| Lymph Nodes | 1 | 2014 | 95 | 0.440 |
Why?
|
| Benzoxazines | 1 | 2011 | 3 | 0.390 |
Why?
|
| Ritonavir | 1 | 2011 | 11 | 0.380 |
Why?
|
| HIV Protease Inhibitors | 1 | 2011 | 14 | 0.380 |
Why?
|
| HIV-1 | 1 | 2011 | 54 | 0.370 |
Why?
|
| Incisional Hernia | 2 | 2022 | 2 | 0.370 |
Why?
|
| Oligopeptides | 1 | 2011 | 95 | 0.360 |
Why?
|
| Hernia, Ventral | 2 | 2022 | 11 | 0.360 |
Why?
|
| Pyridines | 1 | 2011 | 99 | 0.360 |
Why?
|
| HIV Infections | 1 | 2011 | 146 | 0.330 |
Why?
|
| Phosphoproteins | 2 | 2005 | 115 | 0.290 |
Why?
|
| Aspirin | 2 | 2005 | 119 | 0.270 |
Why?
|
| Cadaver | 2 | 2018 | 57 | 0.270 |
Why?
|
| Male | 11 | 2019 | 12870 | 0.240 |
Why?
|
| Serine | 1 | 2004 | 48 | 0.230 |
Why?
|
| Middle Aged | 6 | 2019 | 6818 | 0.220 |
Why?
|
| Adipose Tissue | 2 | 2005 | 178 | 0.220 |
Why?
|
| Sepsis | 1 | 2004 | 81 | 0.220 |
Why?
|
| Insulin Resistance | 1 | 2004 | 165 | 0.210 |
Why?
|
| Humans | 12 | 2022 | 26829 | 0.200 |
Why?
|
| Simulation Training | 1 | 2022 | 19 | 0.200 |
Why?
|
| Adult | 5 | 2019 | 7383 | 0.200 |
Why?
|
| Robotics | 1 | 2022 | 42 | 0.200 |
Why?
|
| Robotic Surgical Procedures | 1 | 2022 | 43 | 0.190 |
Why?
|
| Laparoscopy | 1 | 2022 | 143 | 0.180 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 578 | 0.170 |
Why?
|
| Young Adult | 2 | 2019 | 2581 | 0.170 |
Why?
|
| Abdominoplasty | 1 | 2019 | 3 | 0.170 |
Why?
|
| Esthetics | 1 | 2019 | 4 | 0.170 |
Why?
|
| Polypropylenes | 1 | 2019 | 6 | 0.170 |
Why?
|
| Female | 4 | 2019 | 14463 | 0.170 |
Why?
|
| Anatomic Landmarks | 1 | 2018 | 14 | 0.160 |
Why?
|
| Swine | 1 | 2019 | 220 | 0.150 |
Why?
|
| Mandible | 1 | 2017 | 41 | 0.140 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 910 | 0.130 |
Why?
|
| Facial Transplantation | 1 | 2014 | 1 | 0.120 |
Why?
|
| Replantation | 1 | 2014 | 7 | 0.120 |
Why?
|
| Lip | 1 | 2014 | 9 | 0.120 |
Why?
|
| Bites and Stings | 1 | 2014 | 6 | 0.120 |
Why?
|
| Amputation, Traumatic | 1 | 2014 | 5 | 0.120 |
Why?
|
| Animals | 5 | 2019 | 9963 | 0.110 |
Why?
|
| Dogs | 1 | 2014 | 504 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2014 | 129 | 0.110 |
Why?
|
| Rats, Wistar | 3 | 2014 | 145 | 0.100 |
Why?
|
| Debridement | 1 | 2012 | 10 | 0.100 |
Why?
|
| Sternotomy | 1 | 2012 | 7 | 0.100 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2012 | 7 | 0.100 |
Why?
|
| Triazoles | 1 | 2012 | 14 | 0.100 |
Why?
|
| Aspergillosis | 1 | 2012 | 11 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2012 | 58 | 0.090 |
Why?
|
| Pyrimidines | 1 | 2012 | 121 | 0.090 |
Why?
|
| Erectile Dysfunction | 1 | 2009 | 13 | 0.090 |
Why?
|
| Gastric Bypass | 1 | 2009 | 17 | 0.080 |
Why?
|
| Aged | 2 | 2017 | 5167 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2009 | 50 | 0.080 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2008 | 4 | 0.080 |
Why?
|
| Prostatic Hyperplasia | 1 | 2008 | 8 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2005 | 22 | 0.070 |
Why?
|
| Urinary Bladder Fistula | 1 | 2007 | 1 | 0.070 |
Why?
|
| Vascular Fistula | 1 | 2007 | 3 | 0.070 |
Why?
|
| Wounds, Gunshot | 1 | 2007 | 17 | 0.070 |
Why?
|
| Embolization, Therapeutic | 1 | 2007 | 45 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2005 | 560 | 0.070 |
Why?
|
| Phosphoserine | 1 | 2005 | 10 | 0.060 |
Why?
|
| Growth Hormone | 1 | 2005 | 102 | 0.060 |
Why?
|
| Anastomosis, Surgical | 2 | 2014 | 37 | 0.060 |
Why?
|
| Rats | 2 | 2005 | 1546 | 0.060 |
Why?
|
| Autografts | 1 | 2022 | 3 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2022 | 221 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2022 | 204 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 980 | 0.040 |
Why?
|
| Jugular Veins | 1 | 2014 | 12 | 0.030 |
Why?
|
| Brazil | 1 | 2014 | 21 | 0.030 |
Why?
|
| Scalp | 1 | 2014 | 13 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2014 | 34 | 0.030 |
Why?
|
| Graft Survival | 1 | 2014 | 27 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 2014 | 10 | 0.030 |
Why?
|
| Nose | 1 | 2014 | 22 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2014 | 41 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2014 | 33 | 0.030 |
Why?
|
| Face | 1 | 2014 | 25 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 40 | 0.030 |
Why?
|
| Microsurgery | 1 | 2014 | 44 | 0.030 |
Why?
|
| Voriconazole | 1 | 2012 | 4 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 747 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 1091 | 0.020 |
Why?
|
| Penile Erection | 1 | 2009 | 3 | 0.020 |
Why?
|
| Prolactin | 1 | 2009 | 16 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2009 | 57 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2009 | 71 | 0.020 |
Why?
|
| Life Style | 1 | 2009 | 83 | 0.020 |
Why?
|
| Estradiol | 1 | 2009 | 174 | 0.020 |
Why?
|
| Urodynamics | 1 | 2008 | 5 | 0.020 |
Why?
|
| Angiography | 1 | 2007 | 35 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2008 | 228 | 0.020 |
Why?
|
| Pelvis | 1 | 2007 | 37 | 0.020 |
Why?
|
| Urography | 1 | 2007 | 12 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 472 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 508 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2005 | 12 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2012 | 2264 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 33 | 0.020 |
Why?
|
| Muscles | 1 | 2005 | 70 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2008 | 1217 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2007 | 464 | 0.010 |
Why?
|
| Receptor, Insulin | 1 | 2005 | 93 | 0.010 |
Why?
|
| Insulin | 1 | 2005 | 310 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 415 | 0.010 |
Why?
|